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Abstract
Background Acellular dermal matrices (ADM) such as
StratticeTM are increasingly used in UK during implant-
based reconstruction. However, there are mixed opinions re-
garding the compatibility of radiotherapy treatment in pre- and
post-reconstructed breasts. The aims of this study are to audit
the rates of radiation induced complications in patients who
underwent breast reconstruction using StratticeTM and estab-
lish whether there is an association between timing of radio-
therapy and complication rates.
Methods Retrospective data collection was performed for all
patients who underwent skin-sparing mastectomy and imme-
diate or delayed StratticeTM-based reconstruction, and re-
ceived pre- or post-reconstruction radiotherapy from July 2010
to November 2014.
Results The age ranged from 33 to 78 years (mean age 51±
10.6) with a mean follow-up time of 21 months. There were
25 StratticeTM-based reconstructions performed. Sixteen had
delayed reconstruction, and 9 had skin-sparing mastectomy
and immediate reconstruction. There were 4 (16 %) aban-
doned procedures due to inability to stretch the mastectomy
flap secondary to poor skin compliance. Two women (8 %)
presented 4 and 9 months later with wound breakdown. One
case (4 %) developed severe capsular contracture following
radiotherapy post-reconstruction and 1 case (4 %) of implant
rupture. There were no episodes of extrusion or implant infec-
tion. Overall complication rates were 32 %. The majority
(75 %) of complications occurred in breasts reconstructed
post-radiotherapy; however, this is not significant when
analysed using chi-square (p=0.43).
Conclusions Our evidence suggests that there is no difference
in complication rates in pre- and post-radiation individuals;
this would suggest that implant-based reconstruction using
StratticeTM should not be an absolute contraindication in
pre- or post-radiotherapy patients. However, when planning
these procedures, it is paramount that the increased risks are
emphasised to patients in order to better manage patient ex-
pectation in cases where complications arise.
Level of Evidence: Level III, risk / prognostic study.
Keywords Acellular dermalmatrix . StratticeTM . Breast
reconstruction . Radiotherapy
Introduction
Increasingly, women are opting for breast reconstruction fol-
lowing breast cancer surgery. The number of implant-based
reconstructions has risen to meet this demand [1]. Acellular
dermal matrices (ADM) such as StratticeTM (LifeCell Corpo-
ration, Houston, Texas, USA) are increasingly used in the UK
to reinforce the lower pole of the breast during implant-based
breast reconstruction [2]. Radiotherapy is an important part of
adjuvant treatment for breast cancer. Following radiotherapy
treatment, the blood supply to the skin can become compro-
mised [3–5]; as a consequence, there is an increased risk of
tissue damage, infection, poor cosmetic outcome and even
loss of the reconstructed breast in the post-radiotherapy pop-
ulation undergoing implant-based reconstruction using ADM
[6–8]. Due to current evidence suggesting an increased risk of
complications in women undergoing ADM-based reconstruc-
tions after completion of radiotherapy, many surgeons shun
these as post-radiation reconstructive options.
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The aims of this study are to audit rates of radiation induced
complications in patients who underwent breast reconstruction
using StratticeTM and establish whether there is an association
between timing of radiotherapy and complication rates.
Patients and methods
Retrospective data collection was performed for all patients
who underwent immediate or delayed StratticeTM-based re-
construction from July 2010 to November 2014 with a focus
on those who received pre- or post-reconstruction radiation.
Patients were offered different reconstructive options based on
the size of their breast. Those with small to moderate size
breast were offered StratticeTM-based reconstruction. Patients
with large, ptotic-shaped breast were offered reconstruction
using dermal sling to reinforce the inframammary pole. Both
groups were offered latissimus dorsi (LD)-based reconstruc-
tion as an alternative or reserve procedure. Ultimately, it was
the patient’s decision on which reconstruction they preferred.
There were two smokers within the group of patients un-
dergoing Strattice-based reconstruction with radiotherapy. Pa-
tients were divided into two groups. Group A delayed recon-
struction (DR) (i.e., radiotherapy prior to reconstruction) and
group B skin-sparing mastectomy (SSR) with immediate re-
construction (IR) (i.e., radiotherapy post-reconstruction). In
group A, there were two patients with previous wide local
excision and radiotherapy. One of these had a recurrence of
cancer and underwent mastectomy with immediate
submuscular implant before a delayed StratticeTM-based re-
construction. Another patient had bilateral breast reduction
but then opted for mastectomy and StratticeTM reconstruction.
There was also one patient that had to undergo a revision
procedure for bottoming out due to a large expander.
Complications evaluated were those related to radiation ex-
posure including failed procedure due to poor skin compliance
with expansion, implant extrusion, capsular formation, wound
infection and wound breakdown resulting in loss of implant.
In group A, the procedure was delayed for a minimum of
1 year following radiotherapy. These patients underwent a
basic clinical evaluation of their mastectomy flap, by
performing a ‘pinch test’ and ‘eye balling’, assessing for skin
elasticity, mobility and for obvious tissue damage due to radi-
ation. Patients were also advised to gently massage the chest
wall with body lotions on daily basis till surgery.
Operative procedure
A single dose of co-amoxiclav (or an alternative in cases of
penicillin allergy) is administered at induction. Once removed
from packaging, StratticeTM then undergoes a thorough
‘washing’ process by hand, in three separate bowls prior to
implantation. This process takes approximately 20–30 min.
Following mastectomy, a subpectoral space is created by dis-
secting the lower border of the pectoralis major (PM) from the
chest wall, as far as the sternum, medially, and up to the point
of proposed cleavage, superiorly. The cavity is washed with
warm saline to remove loose debris and fat. A 10×16-cm
piece of StratticeTM is laid behind the lower mastectomy flap.
The 1st suture is centred in the Strattice TM and the mid arc of
the inframammary fold (IMF). The matrix is then anchored by
way of three-point fixation through the StratticeTM, the medial
pole of PM and the medial limit of the IMF. Multiple
interrupted sutures are then placed along the IMF as far, later-
ally, as the anterior axillary line. The cavity is measured and an
appropriate expander is selected, matching the dimensions
and placed in the subpectoral pouch created. Excess
StratticeTM is not trimmed but laid flat behind the pectoralis
major in front of the expander without any folds. The PM is
sutured to the matrix using inverted horizontal mattress su-
tures. Closure of the lateral space is performed to avoid mi-
gration of expander into the axilla. A single drain is placed,
running along the IMF, between the skin and the matrix. A
second drain is placed in the axilla for patients who underwent
axillary clearance. A fully inflated expander was used for all
skin-sparingmastectomies. In cases of delayed reconstruction,
the amount of fluid in the expander was dependent on the
subpectoral space. Patients are kept overnight for 24 h of
intravenous antibiotics and discharged home with 1 week of
oral antibiotics. The drain is removed when there is less than
30 ml of output per 24 h for two consecutive days. If output
remains persistent, the drain is removed at 3 weeks post-op-
eratively. Patients are instructed to wear a support bra for
6 weeks. Initial follow-up occurs on post-operative day 5 for
a wound check. This is performed by a breast specialist nurse.
No community nurse was involved at any stage of the wound
care.
Patients who have had a DR undergo inflation of the ex-
pander by a dedicated breast specialist nurse at least 5 weeks
after surgery. The amount of fluid injected is variable and
adjusted on an individual basis. In those having immediate
reconstruction, following multidisciplinary review, the pa-
tients are referred to oncologists for further chemotherapy or
radiotherapy treatment as required.
In those with DR, all patients underwent a second proce-
dure to replace the expanders with implants after full expan-
sion was achieved. The procedure was abandoned if skin be-
came tight and shiny, and there was suspicion of failed infla-
tion. Those with IR waited a further 6 months after radiation
before an exchange procedure is performed.
Results
There were 64 Strattice TM-based reconstructions identified
that were performed from July 2010 to November 2014.
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Those who chose this preferred a less extensive surgery first
rather than the more extensive LD reconstruction. The age
ranged from 33–78 years (mean age 51±10.6). Every case
will be followed up for 5 years as part of their treatment fol-
lowing breast cancer diagnosis with a mean time of
21 months.
A total of 25 cases of StratticeTM-based reconstruction had
adjuvant radiotherapy. Of these, we report 8 cases (32 %) of
complications requiring removal of implants. There were 4
cases (16 %) with poor skin compliance, where the skin failed
to expand following inflation of expander; 2 cases (8 %) with
wound break down after 4 and 9 months, respectively; 1 case
(4 %) developed severe capsular contracture of the recon-
structed breast and 1 case (4 %), where the implant ruptured.
See Table 1 for a summary of complications.
The patients were further divided, and a breakdown of
complications by groups and further procedures performed
is shown in Table 2. The majority (75 %) of complications




Complications Marginal row totals
Group A 10 (10.88) [0.07] 6 (5.12) [0.15] 16
Group B 7 (6.12) [0.13] 2 (2.88) [0.27] 9
Marginal
column totals
17 8 25 (grand total)
Chi-square analysis demonstrated independence of the
timing of radiotherapy and the risk of developing complica-
tions (p=0.43).
Discussion
StratticeTM is non cross-linked acellular matrix which is de-
rived from porcine dermis. Using this as a connective tissue
graft material improves the quality of soft tissue in implant-
based breast reconstruction [9]. StratticeTM incorporates into
the recipient tissue with associated cells and microvascular
ingrowths. It is completely an avascular tissue and gets
vascularised from surrounding healthy tissue starting as early
as around 2 weeks post-implantation and mature vascular
structure at 6 months [9, 10].
It is known that stretching of tissue is associated with a
significantly higher complication rate [11–15]. If radiation is
given to this tissue, it is thought to add to further complica-
tions. Radiotherapy adversely affects hair, sweat and seba-
ceous gland function required for re-epithelialisation and
wound repair and, in this way, compromises wound healing
[3–5]. Some researchers believe the effect of radiation is sim-
ilar to that of heavy smokers and discourage breast reconstruc-
tion in such cases [16]. However, there are studies which
claim its protective effect, limiting chronic inflammation
when exposed to radiation and subsequently reducing capsule
formation [8]. In our group of patients, none of the smokers
developed any complications but due to the small numbers,
we are unable to suggest whether smoking is a risk factor or
whether radiation provided any protection.
Park et al. had shown a high implant loss of 28 % [6]. In a
very recent study by Barber et al. [7], the reconstruction loss
rate was quoted to be as high as 47.6 %. Current general
opinion is that radiation is a risk for higher rate of ADM
complications as such there is a bias in terms of amount of
information available regarding this [17]. With the emergence
of data suggesting the protective effect of ADM, it is neces-
sary to identify the consequence of timing of radiation in
ADM reconstruction [8]. Furthermore, Barber [7] also de-
scribes that most complications happen in those receiving
pre-radiotherapy reconstruction. In the present study, the ma-
jority of patients had delayed reconstruction, having already
Table 1 Complications
Complication Number of cases, N (%)
Poor skin compliance 4 (16)
Wound breakdown 2 (8)
Severe capsular contracture 1 (4)
Implant rupture 1 (4)
Total 8 (32)
Table 2 Complications and further procedures
Complications Number of patients (N) Further procedures
Group A Poor skin compliance N=4/16 (25 %) Three LD-based reconstruction
One declined further surgery
Wound break down N=2/16 (12.5 %) Implants removed and LD reconstructions
Group B Rupture of expander N=1/9 (11.1 %) Replaced with new ones
Severe capsular contracture N=1/9 (11.1 %) LD reconstruction
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completed their oncological treatment. Of those who had pre-
radiotherapy reconstruction, there was only one patient who
developed severe contracture but this did not delay treatment.
Overall significant complications were 32 % in our study.
Perhaps, surprisingly, there were no cases of infection noted in
either group. In a study by Mitchel et al. [3], they attributed
their low complication and infection to a thorough antibiotic
irrigation of the subpectoral pocket, soaking of implant in
antibiotic solution and adequate drainage of the cavity. We
believe that among these, only adequate drainage of seroma
had a major role to play in our study group to minimise infec-
tion. For this reason, we emphasise on suturing StratticeTM
without folds, adequately filling the expander to close any
dead space between it and mastectomy flap and removing
the drain when there was minimal output.
The major limitation to this study is the relatively short
duration of follow-up. It is entirely possible that in time, this
population of patients could develop further wound problems
or extrusion of implants. However, this is unpredictable as
there is a paucity of data regarding the long-term outcomes
in this population.
Although this present patient population is small and
heterogenic, our results encourage us to continue to offer pa-
tients delayed and immediate reconstruction after thorough
counselling and clear information provided to the patients of
the high risk of reconstructive failure.
Conclusion
The evidence suggests that implant-based reconstruction
using StratticeTM should not be contraindicated in pre or
post-radiotherapy patients. However, when planning these
procedures, it is paramount that the increased risks are
emphasised to patients in order to better manage patient ex-
pectation in cases where complications arise.
Acknowledgments Wewould like to thank Lynn Pounder, a breast care
specialist nurse, for her involvement in data collection and her continuous
care for the patients in this article.
Ethical standards For this retrospective study formal consent from a
local ethics committee is not required.
Funding There was no external funding for the study.
Conflict of interest Cho Ee Ng, Andrew Pieri and Tarannum Fasih
declare that they have no conflict of interest.
Patient consent Patients provided written consent prior to their inclu-
sion in the study.
References
1. Lardi AM, Ho-Asjoe M, Mohanna P-N, Farhadi J (2014)
Immediate breast reconstruction with acellular dermal matrix: fac-
tors affecting outcome. J Plast Reconstr Aesthet Surg 67:1098–
1105
2. Hirsch EM, Dumanian GA (2012) Discussion: AlloDerm and
Strattice in breast reconstruction: a comparison and techniques for
optimizing outcomes. Plast Reconstr Surg 129:1234–1235
3. Mitchell RE (2013) Porcine acellular dermis-assisted breast recon-
struction: influence of adjuvant radiotherapy on complications and
outcomes. Plast Reconstr Surg Glob open 1:e77
4. Bernstein EF, Sullivan FJ, Mitchell JB et al (1993) Biology of
chronic radiation effect on tissues and wound healing. Clin Plast
Surg 20:435–453
5. Burns JL, Mancoll JS, Phillips LG (2003) Impairments to wound
healing. Clin Plast Surg 30:47–56
6. Parks JW, Hammond SE, Walsh WA et al (2012) Human acellular
dermis versus no acellular dermis in tissue expansion breast recon-
struction. Plast Reconstr Surg 130:739–746
7. Barber MD, Williams L, Anderson EDC et al (2015) Outcome
of the use of acellular-dermal matrix to assist implant-based
breast reconstruction in a single centre. Eur J Surg Oncol 41:
100–105
8. Moyer HR, Pinell-White X, Losken A (2014) The effect of radia-
tion on acellular dermal matrix and capsule formation in breast
reconstruction: clinical outcomes and histologic analysis. Plast
Reconstr Surg 133:214–221
9. Himsl I, Drinovac V, Lenhard M et al (2012) The use of porcine
acellular dermal matrix in silicone implant-based breast reconstruc-
tion. Arch Gynecol Obstet 286:187–192
10. Connor J, McQuillan D, Sandor M et al (2009) Retention of struc-
tural and biochemical integrity in a biological mesh supports tissue
remodeling in a primate abdominal wall model. RegenMed 4:185–
195
11. Hughes K, BrownC, Perez Vet al (2012) The effect of radiotherapy
on implant-based breast reconstruction in the setting of skin-sparing
mastectomy: clinical series and review of complications.
Anticancer Res 32:553–557
12. McCraw JB, Horton CE, Grossman JA et al (1987) An early ap-
praisal of the methods of tissue expansion and the transverse rectus
abdominis musculocutaneous flap in reconstruction of the breast
following mastectomy. Ann Plast Surg 18:93–113
13. Kroll SS, Baldwin B (1992) A comparison of outcomes using three
different methods of breast reconstruction. Plast Reconstr Surg 90:
455–462
14. Disa JJ, Cordeiro PG, Heerdt AH et al (2003) Skin-sparing mastec-
tomy and immediate autologous tissue reconstruction after whole-
breast irradiation. Plast Reconstr Surg 111:118–124
15. Tadiparthi S, Alrawi M, Collis N (2011) Two-stage delayed breast
reconstruction with an expander and free abdominal tissue transfer:
outcomes of 65 consecutive cases by a single surgeon. J Plast
Reconstr Aesthet Surg 64:1608–1612
16. Nava MB, Cortinovis U, Ottolenghi J et al (2006) Skin-reducing
mastectomy. Plast Reconstr Surg 118:603–610
17. Valdatta L, Cattaneo AG, Pellegatta I et al (2014) Acellular dermal
matrices and radiotherapy in breast reconstruction: a systematic
review and meta-analysis of the literature. Plast Surg Int 2014:
472604
462 Eur J Plast Surg (2015) 38:459–462
